Search Results

FILTER BY

1 - 12 of 39 matches

Sort by:
  • PresentationTCT 2023

    TCT 606: Alterations in the Endothelial Wall Shear Stress Due to the Presence of the Stent Footprint: Comparison Between Xience and Resolute Stent Platforms

    Presenter:  

    Imran Shah

    October 25, 2023

  • PresentationTCT 2022

    TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy

    Presenter:  

    Mick Renkens

    September 17, 2022

  • PresentationTCT 2020

    The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients

    Presenter:  

    Roxana Mehran

    October 15, 2020

  • PresentationTCT 2020

    TCT 167: Comparison of Stent Expansion Between Xience and Orsiro Stents in Heavily Calcified Coronary Arteries in Cadaver Heart

    Presenter:  

    Yu Sato

    October 14, 2020

  • PresentationTCT 2019

    The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

    Presenter:  

    Azeem Latib

    September 28, 2019

  • PresentationTCT 2019

    The Science Behind Xience: From EXCEL to Short DAPT

    Presenter:  

    Sripal Bangalore

    September 28, 2019

  • PresentationTCT 2019

    XIENCE/ ONYX Short DAPT Programs

    Presenter:  

    Mitchell Krucoff

    September 27, 2019

  • PresentationTCT Abstracts Posters 2018

    Comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polimer coated everolimus-eluting Xience stent: 6- and 24-months results of the DESSOLVE III OCT sub-study

    Presenter:  

    Krzysztof Milewski

    September 25, 2018

  • PresentationTCT 2017

    XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

    Presenter:  

    David E. Kandzari, Stephen G. Ellis, Tullio Palmerini

    October 30, 2017

  • PresentationTCT 2017

    Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

    Presenter:  

    C. Michael Gibson, Stephan Windecker

    October 30, 2017

  • PresentationTCT 2016

    BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

    Presenter:  

    Corrado Tamburino, Patrick W. Serruys, Stephen G. Ellis

    October 31, 2016

  • PresentationTCT 2016

    TCT 70: Final 5 Year Results from the COMPARE II Trial: Comparison Between the Durable Polymer Coated Everolimus-Eluting Xience/Promus Stent and the Biodegradable Polymer Coated Biolimus-Eluting Nobori Stent in All-Comer Population

    Presenter:  

    Christoph A. Kaiser, Giuseppe De Luca, Pieter C. Smits

    October 31, 2016